Clinical Trial Update: Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating pembrolizumab in combination with hypofractionated stereotactic radiotherapy for advanced malignant pleural mesothelioma; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Advanced Malignant Pleural Mesothelioma | Phase 1 | Status: TERMINATED | Results posted: 2026-02-04